Extreme heat has caused more than 24,000 deaths since 1992 and has...
Category:
Health
Latest
Principal Secretary to PM chairs high-level meeting amid COVID-19 rise, stresses on 5-fold strategy
India recorded 12,591 new Covid cases in a day, the highest in...
India overtakes China to become most populous country: UN report
The latest UNFPA report stated that in India 25 per cent of the...
HDFC Life & HDFC Ergo launch a combi protection plan with term & COVID-19 health cover in a single policy.
HDFC Life’s C2P3D Plus is one of the most flexible and customizable term plans in the market. HDFC Ergo’s Corona Kavach is an indemnity health policy that was launched earlier this year to offer cover against medical expenses incurred due to hospitalization of individuals seeking treatment for COVID-19, on a positive diagnosis for the virus, in a government authorized diagnostic centre
As India readies vaccine strategy, Modi warns of possible side-effects
The question of who pays any claims for damages for unexpected side-effects has been a tricky point in supply negotiations between countries and drug makers over potential vaccines. Some richer countries have agreed full or partial exemptions from liability for firms to secure shots.
AstraZeneca and Oxford say COVID-19 vaccine shows 70% efficacy
AstraZeneca chief executive Pascal Soriot said that the lower first dose of its experimental COVID-19 vaccine meant more people can be vaccinated more quickly, as the British drugmaker unveiled interim late-stage trial results.
“Being able to vaccinate more people faster is a really a big plus,” he told a briefing.AstraZeneca said it would “immediately prepare regulatory submission of the data to authorities around the world that have a framework in place for conditional or early approval.”
The Astra vaccine does not require ultra-cold storage which may make it easier to administer than the Pfizer-BioNTech shot, which needs to be refrigerated at -70 degrees.
SC says COVID-19 situation worsened in Delhi & Guj, asks Centre, states to file status reports
The top court said all efforts shall be made by the Centre and the states to mitigate the situation and to deal with the rising number of COVID-19 cases.
Maha makes RT-PCR negative report mandatory for entering state
“The passengers without symptoms will be allowed entry. Passengers with symptoms shall have the option of turning back and going to their home to recuperate,” the order said.
The order stipulated that all domestic passengers traveling from airports in NCR Delhi, Rajasthan, Gujarat and Goa shall carry RT-PCR negative test reports with them before boarding and show them to the teams at the arrival airport in Maharashtra.
Airline body IATA develops mobile apps for COVID-era travel
“Our main priority is to get people travelling again safely,” IATA security chief Nick Careen said. “That means giving governments confidence that systematic COVID-19 testing can work as a replacement for quarantine requirements.”
Passenger health and other data are not stored centrally but authenticated with blockchain, leaving consumers in control of what they share, IATA said.
COVID-19 caseload in India breaches 91-lakh mark
The national recovery rate was recorded 93.68per cent,while the COVID-19 case fatality rate stands at 1.46 per cent
India’s COVID-19 tally rises to 90.95 lakh with 45,209 new cases
The total recoveries have surged to 85,21,617, pushing the national recovery rate to 93.69 per cent, while the COVID-19 case fatality rate has declined to 1.46 per cent.
There are 4,40,962 active cases in the country as on date which comprise 4.85 per cent of the total caseload, the data stated.
Moderna to charge govts $25-$37 for Covid-19 vaccine: CEO
“Our vaccine therefore costs about the same as a flu shot, which is between $10 and $50,” he was quoted as saying.
U.S. FDA grants emergency use authorization to Regeneron COVID-19 antibody given to Trump
Regeneron said on Saturday the clinical evidence from outpatient trial suggests that monoclonal antibodies such as REGEN-COV2 have the greatest benefit when given early after diagnosis and in patients who have not yet mounted their own immune response or who have high viral load